BOB Intellectual Property Service Ltd.
  • 中文
  • 日本語
  • English
  • Company profile
    • About Us
    • Affiliated Law Firm
    • BOB Clients
    • BOB News
    • Join us
      • Client Service Department
      • Law Affair Department
      • Trademark Department
      • Investigation Department
      • Other Departments
    • Contact Us
  • Service associated
    with Trademark
    • Trademark Application
      • Trademark Search
      • Procedures of trademark registration
    • Trademark monitoring
    • Opposition of trademark
    • Registration similar trademarks
    • Protection of trademark right
    • Fees Information
  • Other Intellectual
    Property Service
    • Copyright registration
    • Patent and design service
  • IPR Protection
    Department
    • Anti-counterfeiting Services
    • Patent protection service
    • Customs protection service
    • Exhibition investigation and rights protection services
    • Anti-trade name unfair competition service
    • Litigation and other legal services
    • Quotation List
  • Solutions To
    Online Infringement
    • Online protection service
    • Features
    • Procedure and cases
  • Reference information
    • News & Insights
      • China IPR News
      • BOB Articles
      • Newsletter
    • Laws & Regulations
      • Trademark
      • Patent
      • Copyright
      • Unfair Competition、Trade Secret
      • Trade Name
      • New Plant Varieties
      • Customs
      • Exhibition
      • Food and Medicine
      • Internet and Domain Name
      • Criminal Cases
      • Notarization
      • International Treaty
      • Others
    • Anti-counterfeiting Campaigns
      • Trademark
      • Patent
      • Copyright
      • Unfair Competition
      • New Plant Varieties
      • Customs
      • Exhibition
      • Food and Medicine
      • Internet and Domain Name
      • Criminal Cases
      • Others
  • Free Consultation
China IPR News
Home » News & Insights » China IPR News » 【Patent】700 million Euros annual sales revenue! The patent of Nexavar (a Bayer anticancer drug) was invalidated.

【Patent】700 million Euros annual sales revenue! The patent of Nexavar (a Bayer anticancer drug) was invalidated.

BOBアーカイブ
  • China IPR News
  • BOB Articles
  • Newsletter


Company profile

  • About Us
  • Affiliated Law Firm
  • BOB Clients
  • BOB News
  • Join Us
  • Contact Us

Services

  • Service associated with Trademark
  • Other Intellectual Property Service
  • IPR Protection Department
  • Solutions To Online Infringement
  • Perennial Advisory Service

News & Insights

  • China IPR News
  • BOB Articles
  • Newsletter

Laws & regulations

  • Trademark
  • Patent
  • Copyright
  • Unfair Competition、Trade Secret
  • Trade Name
  • New Plant Varieties
  • Customs
  • Exhibition
  • Food and Medicine
  • Internet and Domain Name
  • Criminal Cases
  • Notarization
  • International Treaty
  • Others

Anti-counterfeiting Campaigns

  • Trademark
  • Patent
  • Copyright
  • Unfair Competition
  • New Plant Varieties
  • Customs
  • Exhibition
  • Food and Medicine
  • Internet and Domain Name
  • Criminal Cases
  • Others

Contact

  • Free Consultation
©2016 BOB Intellectual Property Service Ltd. All rights reserved. 沪ICP备07020976号-1